Cancers, Vol. 9, Pages 150: CAR-T Cell Therapy: From the Bench to the Bedside
Cancers doi: 10.3390/cancers9110150
Authors: Vita Golubovskaya
CAR (Chimeric Antigen receptor)-T cell therapy is a novel type of therapy that uses engineered T cells with an antibody single-chain variable fragment (ScFv) extracellular domain that binds tumor-associated antigens[...]
from Cancer via ola Kala on Inoreader http://ift.tt/2yZCQ6z
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου